Ability of innate defence regulator peptides IDR-1002, IDR-HH2 and IDR-1018 to protect against Mycobacterium tuberculosis infections in animal models.
Tuberculosis is an ongoing threat to global health, especially with the emergence of multi drug-resistant (MDR) and extremely drug-resistant strains that are motivating the search for new treatment strategies. One potential strategy is immunotherapy using Innate Defence Regulator (IDR) peptides that...
Main Authors: | Bruno Rivas-Santiago, Julio E Castañeda-Delgado, Cesar E Rivas Santiago, Matt Waldbrook, Irma González-Curiel, Juan C León-Contreras, Jose Antonio Enciso-Moreno, Victor del Villar, Jazmin Mendez-Ramos, Robert E W Hancock, Rogelio Hernandez-Pando |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3605426?pdf=render |
Similar Items
-
Synthetic cationic peptide IDR-1018 modulates human macrophage differentiation.
by: Olga M Pena, et al.
Published: (2013-01-01) -
Impacts of PEGylation and Glycosylation on the Biological Properties of Host Defense Peptide IDR1018
by: Hashem Etayash, et al.
Published: (2023-05-01) -
Synthetic host defense peptide IDR-1002 reduces inflammation in Pseudomonas aeruginosa lung infection.
by: Kelli C Wuerth, et al.
Published: (2017-01-01) -
IDR (Industrial Diamond Review)
Published: (1941) -
Modulation of the immune response by the host defense peptide IDR-1002 in chicken hepatic cell culture
by: Csilla Sebők, et al.
Published: (2023-09-01)